✦ LIBER ✦

A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy

✍ Scribed by Richard F Kefford; Philip R Clingan; Benjamin Brady; Andrea Ballmer; Adele Morganti; Peter Hersey

Book ID: 119902067
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 705 KB
Volume: 9
Category: Article
ISSN: 1476-4598
DOI: 10.1186/1476-4598-9-69

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised, placebo-controlled, double-b

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

✍ Rougier, Philippe; Riess, Hanno; Manges, Robert; Karasek, Petr; Humblet, Yves; B 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 916 KB

Bevacizumab in Combination With Chemothe

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

✍ Ohtsu, A.; Shah, M. A.; Van Cutsem, E.; Rha, S. Y.; Sawaki, A.; Park, S. R.; Lim 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 203 KB

Use of physiological doses of human grow

Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study

✍ Sirohi, B; Powles, R; Morgan, G; Treleaven, J; Kulkarni, S; Horton, C; Saso, R; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

Use of physiological doses of human grow

Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study

✍ Sirohi, B; Powles, R; Morgan, G; Treleaven, J; Kulkarni, S; Horton, C; Saso, R; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

5-31-15 A double-blind, randomized, plac

5-31-15 A double-blind, randomized, placebo-controlled study of oral high-dose methylprednisolone in patients with attacks of multiple sclerosis

✍ Sellebjerg, F.; Frederiksen, J.L.; Christiansen, M.; Nielsen, P.M.; Olesen, J. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Nadroparin for the prevention of thrombo

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

✍ Giancarlo Agnelli; Gualberto Gussoni; Carlo Bianchini; Melina Verso; Mario Manda 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 163 KB